The relationship of tidal volume and driving pressure with mortality in hypoxic patients receiving mechanical ventilation.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
05
2021
accepted:
23
07
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
15
12
2021
Statut:
epublish
Résumé
To determine whether tidal volume/predicted body weight (TV/PBW) or driving pressure (DP) are associated with mortality in a heterogeneous population of hypoxic mechanically ventilated patients. A retrospective cohort study involving 18 intensive care units included consecutive patients ≥18 years old, receiving mechanical ventilation for ≥3 days, with a PaO2/FiO2 ratio ≤300 mmHg, whether or not they met full criteria for ARDS. The main outcome was hospital mortality. Multiple logistic regression (MLR) incorporated TV/PBW, DP, and potential confounders including age, APACHE IVa® predicted hospital mortality, respiratory system compliance (CRS), and PaO2/FiO2. Predetermined strata of TV/PBW were compared using MLR. Our cohort comprised 5,167 patients with mean age 61.9 years, APACHE IVa® score 79.3, PaO2/FiO2 166 mmHg and CRS 40.5 ml/cm H2O. Regression analysis revealed that patients receiving DP one standard deviation above the mean or higher (≥19 cmH20) had an adjusted odds ratio for mortality (ORmort) = 1.10 (95% CI: 1.06-1.13, p = 0.009). Regression analysis showed a U-shaped relationship between strata of TV/PBW and adjusted mortality. Using TV/PBW 4-6 ml/kg as the referent group, patients receiving >10 ml/kg had similar adjusted ORmort, but those receiving 6-7, 7-8 and 8-10 ml/kg had lower adjusted ORmort (95%CI) of 0.81 (0.65-1.00), 0.78 (0.63-0.97) and 0.80 0.67-1.01) respectively. The adjusted ORmort in patients receiving 4-6 ml/kg was 1.26 (95%CI: 1.04-1.52) compared to patients receiving 6-10 ml/kg. Driving pressures ≥19 cmH2O were associated with increased adjusted mortality. TV/PBW 4-6ml/kg were used in less than 15% of patients and associated with increased adjusted mortality compared to TV/PBW 6-10 ml/kg used in 82% of patients. Prospective clinical trials are needed to prove whether limiting DP or the use of TV/PBW 6-10 ml/kg versus 4-6 ml/kg benefits mortality.
Identifiants
pubmed: 34370773
doi: 10.1371/journal.pone.0255812
pii: PONE-D-21-17095
pmc: PMC8351937
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255812Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Crit Care. 2017 Jan 20;21(1):12
pubmed: 28107822
N Engl J Med. 1998 Feb 5;338(6):347-54
pubmed: 9449727
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Crit Care Med. 2005 May;33(5):1141-3
pubmed: 15891350
Ann Am Thorac Soc. 2017 Nov;14(11):1682-1689
pubmed: 28771042
BMJ. 2012 Apr 05;344:e2124
pubmed: 22491953
JAMA. 2012 Oct 24;308(16):1651-9
pubmed: 23093163
Ann Am Thorac Soc. 2016 Jul;13(7):1123-8
pubmed: 27159648
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1722-37
pubmed: 7952641
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Chest. 2001 Nov;120(5):1622-7
pubmed: 11713144
Crit Care Med. 2006 Jan;34(1):8-14
pubmed: 16374150
Shock. 2018 Mar;49(3):311-316
pubmed: 28846571
Ann Transl Med. 2018 Oct;6(19):393
pubmed: 30460267
Crit Care. 2010;14(1):R1
pubmed: 20055989
Ann Am Thorac Soc. 2019 Oct;16(10):1263-1272
pubmed: 31247145
Am J Respir Crit Care Med. 1998 Dec;158(6):1831-8
pubmed: 9847275
Lancet. 1967 Aug 12;2(7511):319-23
pubmed: 4143721
J Crit Care. 1996 Mar;11(1):9-18
pubmed: 8904279
Clin Chest Med. 2016 Dec;37(4):633-646
pubmed: 27842744
Am J Respir Crit Care Med. 2003 Mar 1;167(5):690-4
pubmed: 12493646
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
JAMA. 2018 Nov 13;320(18):1872-1880
pubmed: 30357256
Chest. 2018 Jan;153(1):46-54
pubmed: 29037528
JAMA. 2002 Jan 16;287(3):345-55
pubmed: 11790214
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1058-68
pubmed: 24070493
Crit Care. 2019 Nov 21;23(1):367
pubmed: 31752980
Crit Care Med. 1993 Jan;21(1):131-43
pubmed: 8420720
Crit Care Med. 1999 Aug;27(8):1492-8
pubmed: 10470755
Crit Care. 2019 Dec 27;23(1):424
pubmed: 31881909
Crit Care Med. 2016 Aug;44(8):1515-22
pubmed: 27035237
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1721-5
pubmed: 9620897
Chest. 1990 Feb;97(2):430-4
pubmed: 2288551
Chest. 2010 Nov;138(5):1054-61
pubmed: 20576730
Chest. 2011 Jul;140(1):9-11
pubmed: 21729888
Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L596-8
pubmed: 15757952
Am J Respir Crit Care Med. 2003 Mar 1;167(5):798; author reply 798-800
pubmed: 12598221
Chest. 2011 Jul;140(1):11-13
pubmed: 21729889
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1471-8
pubmed: 9817695
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Am J Respir Crit Care Med. 2002 Dec 1;166(11):1510-4
pubmed: 12406836
Crit Care Med. 2018 Feb;46(2):300-306
pubmed: 29135500
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Crit Care Med. 2017 May;45(5):843-850
pubmed: 28252536
Mayo Clin Proc. 2017 Sep;92(9):1382-1400
pubmed: 28870355
Chest. 2018 Feb;153(2):361-367
pubmed: 29248620
Intensive Care Med. 2006 Oct;32(10):1515-22
pubmed: 16896854
Crit Care Med. 2006 May;34(5):1297-310
pubmed: 16540951
N Engl J Med. 2015 Feb 19;372(8):776-7
pubmed: 25693019